Get started
Work

Abstract LB359: The Bcl-xL specific PROTAC, DT2216, increases the sensitivity to target therapy of preclinical tumor models from different origin

Year: 2026
Type: conference-abstract
DOI: 10.1158/1538-7445.am2026-lb359
Authors: Giulia Gentile, Elisabetta Valentini, Marta Di Martile, Simona D'Aguanno, Matteo Brignone, Adriana Maria Di Stefano, Marica Di Caprio, Elisa Melucci, Claudio Botti, Fabio Pelle, Arianna Ortolano, Luigi Fattore, Rita Mancini, Gennaro Ciliberto, Dante Rotili, Michela Chiappa, Giovanna Damia, Donatella Del Bufalo
Institutions: Istituti di Ricovero e Cura a Carattere Scientifico, Instituto Nazionale Tumori Regina Elena, University of Siena, Sapienza University of Rome, Link Campus University, Roma Tre University, Mario Negri Institute for Pharmacological Research
Language: English
Open Access status: closed
OpenAlex ID: W7154683070
Cites:
Cited by:
Related to: